目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Point-of-Care Molecular Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. User perspective analysis
3.3.1. Consumer Behavior Analysis
3.3.2. Market Influencer Analysis
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.5. Point-of-Care Molecular Diagnostics: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape

Chapter 4. Point-of-Care Molecular Diagnostics Market: Segment Analysis, By Application, 2022 - 2030 (USD Million)
4.1. Definitions & Scope
4.2. Application market share analysis, 2022 & 2030
4.3. Global Point-of-Care Molecular Diagnostics Market, By Application, 2018 to 2030
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Infectious Diseases
4.4.1.1. HIV POC
4.4.1.2. Clostridium difficile POC
4.4.1.3. HBV POC
4.4.1.4. Pneumonia or Streptococcus associated infections
4.4.1.5. Respiratory syncytial virus (RSV) POC
4.4.1.6. HPV POC
4.4.1.7. Influenza/Flu POC
4.4.1.8. HCV POC
4.4.1.9. MRSA POC
4.4.1.10. TB and drug-resistant TB POC
4.4.1.11. HSV POC
4.4.1.12. Other Infectious Diseases
4.4.2. Oncology
4.4.3. Hematology
4.4.4. Prenatal Testing
4.4.5. Endocrinology
4.4.6. Other Applications

Chapter 5. Point-of-Care Molecular Diagnostics Market: Segment Analysis, By Technology, 2022 - 2030 (USD Million)
5.1. Definitions & Scope
5.2. Technology market share analysis, 2022 & 2030
5.3. Global Point-of-Care Molecular Diagnostics Market, By Technology, 2018 to 2030
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. PCR-based
5.4.2. Genetic Sequencing-based
5.4.3. Hybridization-based
5.4.4. Microarray-based

Chapter 6. Point-of-Care Molecular Diagnostics Market: Segment Analysis, By End Use, 2022 - 2030 (USD Million)
6.1. Definitions & Scope
6.2. End-use market share analysis, 2022 & 2030
6.3. Global Point-of-Care Molecular Diagnostics Market, By End Use, 2018 to 2030
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Decentralized Labs
6.4.2. Hospitals
6.4.3. Home-care
6.4.4. Assisted Living Healthcare Facilities
6.4.5. Other uses

Chapter 7. Point-of-Care Molecular Diagnostics Market: Segment Analysis, By Test Location, 2022 - 2030 (USD Million)
7.1. Definitions & Scope
7.2. Test location market share analysis, 2022 & 2030
7.3. Global Point-of-Care Molecular Diagnostics Market, By Test Location, 2018 to 2030
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. OTC
7.4.2. POC

Chapter 8. Point-of-Care Molecular Diagnostics Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)
8.1. Definitions & Scope
8.2. Regional market share analysis, 2022 & 2030
8.3. Regional Market Dashboard
8.4. Regional Market: Key Players
8.5. Market Size, & Forecasts, and Trend Analysis, 2022 to 2030:
8.6. North America
8.6.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.6.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.6.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.6.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.6.5. U.S.
8.6.5.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.6.5.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.6.5.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.6.5.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.6.6. Canada
8.6.6.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.6.6.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.6.6.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.6.6.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7. Europe
8.7.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7.5. Germany
8.7.5.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.5.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.5.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.5.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7.6. U.K.
8.7.6.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.6.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.6.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.6.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7.7. France
8.7.7.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.7.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.7.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.7.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7.8. Italy
8.7.8.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.8.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.8.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.8.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7.9. Spain
8.7.9.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.9.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.9.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.9.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7.10. Sweden
8.7.10.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.10.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.10.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.10.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7.11. Denmark
8.7.11.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.11.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.11.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.11.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.7.12. Norway
8.7.12.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.12.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.7.12.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.7.12.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.8. Asia Pacific
8.8.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.8.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.8.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.8.5. China
8.8.5.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.5.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.8.5.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.8.5.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.8.6. Japan
8.8.6.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.6.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.8.6.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.8.6.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.8.7. India
8.8.7.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.7.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.8.7.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.8.7.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.8.8. Australia
8.8.8.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.8.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.8.8.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.8.8.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.8.9. South Korea
8.8.9.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.9.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.8.9.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.8.9.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.8.10. Thailand
8.8.10.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.10.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.8.10.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.8.10.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.9. Latin America
8.9.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.9.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.9.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.9.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.9.5. Brazil
8.9.5.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.9.5.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.9.5.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.9.5.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.9.6. Mexico
8.9.6.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.9.6.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.9.6.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.9.6.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.9.7. Argentina
8.9.7.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.9.7.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.9.7.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.9.7.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.10. Middle East and Africa
8.10.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.10.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.10.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.10.5. South Africa
8.10.5.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10.5.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.10.5.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.10.5.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.10.6. Saudi Arabia
8.10.6.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10.6.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.10.6.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.10.6.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.10.7. UAE
8.10.7.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10.7.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.10.7.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.10.7.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)
8.10.8. Kuwait
8.10.8.1. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10.8.2. Market estimates and forecast, By Technology, 2018 - 2030 (USD Million)
8.10.8.3. Market estimates and forecast, By Test Location, 2018 - 2030 (USD Million)
8.10.8.4. Market estimates and forecast, by End-Use, 2018 - 2030 (USD Million)

Chapter 9. Point-of-Care Molecular Diagnostics Market - Competitive Analysis
9.1. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
9.2. Vendor Landscape
9.2.1. List of key distributors and channel partners
9.3. Key companies profiled
9.3.1. Abbott
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Bayer AG
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. F. Hoffmann-La Roche AG
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Nova Biomedical
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. QIAGEN
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Nipro Diagnostics
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Danaher
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Bio-Rad Laboratories, Inc.
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. bioMérieux
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Agilent Technologies, Inc.
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Abaxis
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. OraSure Technologies
9.3.12.1. Company Overview
9.3.12.2. Financial Performance
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives

List of Tables
TABLE 1. Point-of-care Molecular Diagnostics market - Industry Snapshot & Key Buying Criteria, 2018 - 2030
TABLE 2. Global Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 3. Global Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 4. Global Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 5. Global Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 6. Global Point-of-care Molecular Diagnostics market, by region, 2018 - 2030 (USD Million)
TABLE 7. Point-of-care Molecular Diagnostics- Key market driver analysis
TABLE 8. Point-of-care Molecular Diagnostics- Key market restraint analysis
TABLE 9. North America Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 10. North America Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 11. North America Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 12. North America Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 13. U.S. Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 14. U.S. Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 15. U.S. Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 16. U.S. Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 17. Canada Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 18. Canada Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 19. Canada Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 20. Canada Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 21. Europe Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 22. Europe Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 23. Europe Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 24. Europe Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 25. Germany Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 26. Germany Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 27. Germany Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 28. Germany Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 29. U.K. Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 30. U.K. Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 31. U.K. Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 32. U.K. Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 33. France Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 34. France Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 35. France Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 36. France Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 37. Italy Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 38. Italy Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 39. Italy Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 40. Italy Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 41. Spain Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 42. Spain Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 43. Spain Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 44. Spain Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 45. Denmark Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 46. Denmark Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 47. Denmark Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 48. Denmark Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 49. Sweden Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 50. Sweden Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 51. Sweden Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 52. Sweden Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 53. Norway Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 54. Norway Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 55. Norway Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 56. Norway Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 57. Asia Pacific Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 58. Asia Pacific Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 59. Asia Pacific Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 60. Asia Pacific Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 61. Japan Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 62. Japan Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 63. Japan Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 64. Japan Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 65. China Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 66. China Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 67. China Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 68. China Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 69. India Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 70. India Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 71. India Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 72. India Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 73. Australia Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 74. Australia Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 75. Australia Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 76. Australia Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 77. South Korea Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 78. South Korea Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 79. South Korea Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 80. South Korea Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 81. Thailand Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 82. Thailand Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 83. Thailand Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 84. Thailand Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 85. Latin America Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 86. Latin America Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 87. Latin America Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 88. Latin America Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 89. Brazil Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 90. Brazil Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 91. Brazil Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 92. Brazil Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 93. Mexico Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 94. Mexico Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 95. Mexico Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 96. Mexico Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 97. Argentina Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 98. Argentina Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 99. Argentina Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 100. Argentina Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 101. MEA Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 102. MEA Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 103. MEA Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 104. MEA Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 105. South Africa Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 106. South Africa Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 107. South Africa Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 108. South Africa Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 109. Saudi Arabia Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 110. Saudi Arabia Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 111. Saudi Arabia Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 112. Saudi Arabia Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 113. UAE Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 114. UAE Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 115. UAE Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 116. UAE Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)
TABLE 117. Kuwait Point-of-care Molecular Diagnostics market, by application, 2018 - 2030 (USD Million)
TABLE 118. Kuwait Point-of-care Molecular Diagnostics market, by technology, 2018 - 2030 (USD Million)
TABLE 119. Kuwait Point-of-care Molecular Diagnostics market, by test location, 2018 - 2030 (USD Million)
TABLE 120. Kuwait Point-of-care Molecular Diagnostics market, by End-use, 2018 - 2030 (USD Million)

List of Figures
Fig 1. Point-of-care Molecular Diagnostics market segmentation
Fig 2. Global Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 3. Point-of-care Molecular Diagnostics market dynamics
Fig 4. Key opportunities prioritized, 2018
Fig 5. Point-of-care Molecular Diagnostics market - Porter’s Analysis
Fig 6. Point-of-care Molecular Diagnostics market - PESTEL analysis
Fig 7. Point-of-care Molecular Diagnostics revenue share, by application, 2022 & 2030
Fig 8. POC MDx Infectious Diseases market, 2018 - 2030 (USD Million)
Fig 9. POC MDx Oncology market, 2018 - 2030 (USD Million)
Fig 10. POC MDx Hematology market, 2018 - 2030 (USD Million)
Fig 11. POC MDx Prenatal Testing market, 2018 - 2030 (USD Million)
Fig 12. POC MDx Endocrinology market, 2018 - 2030 (USD Million)
Fig 13. POC MDx Other Applications market, 2018 - 2030 (USD Million)
Fig 14. Point-of-care Molecular Diagnostics revenue share, by technology, 2022 & 2030
Fig 15. POC MDx PCR-based market, 2018 - 2030 (USD Million)
Fig 16. POC MDx Genetic Sequencing-based market, 2018 - 2030 (USD Million)
Fig 17. POC MDx Hybridization-based market, 2018 - 2030 (USD Million)
Fig 18. POC MDx Microarray-based market, 2018 - 2030 (USD Million)
Fig 19. Point-of-care Molecular Diagnostics revenue share, by test location, 2022 & 2030
Fig 20. POC MDx over-the-counter market, 2018 - 2030 (USD Million)
Fig 21. POC MDx point-of-care market, 2018 - 2030 (USD Million)
Fig 22. Point-of-care Molecular Diagnostics revenue share, by End-use, 2022 & 2030
Fig 23. POC MDx Decentralized Labs market, 2018 - 2030 (USD Million)
Fig 24. POC MDx Hospitals market, 2018 - 2030 (USD Million)
Fig 25. POC MDx Home-care market, 2018 - 2030 (USD Million)
Fig 26. POC MDx Assisted Living Healthcare Facilities market, 2018 - 2030 (USD Million)
Fig 27. POC MDx Other uses market, 2018 - 2030 (USD Million)
Fig 28. Point-of-care Molecular Diagnostics revenue share, by region, 2022 & 2030
Fig 29. North America Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 30. U.S. Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 31. Canada Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 32. Europe Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 33. Germany Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 34. U.K. Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 35. France Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 36. Italy Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 37. Spain Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 38. Denmark Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 39. Sweden Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 40. Norway Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 41. Asia Pacific Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 42. Japan Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 43. China Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 44. India Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 45. Australia Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 46. South Korea Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 47. Thailand Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 48. Latin America Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 49. Brazil Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 50. Mexico Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 51. Argentina Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 52. MEA Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 53. South Africa Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 54. Saudi Arabia Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 55. UAE Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)
Fig 56. Kuwait Point-of-care Molecular Diagnostics market, 2018 - 2030 (USD Million)